Surgical & Medical Instruments & Apparatus
Standard Industrial Classification: SIC 3841
Industry Insider Sentiment Analysis
The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2017-03-07 00:09 | 2017-03-02 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | Murphy Raymond G. | Director | OPT+S | $43.01 | 5,238 | $225,268 | 60,894 |
| 2017-03-07 00:02 | 2017-03-03 | RMD | RESMED INC | PENDARVIS DAVID | Officer | OPT+S | $72.22 | 6,365 | $459,680 | 77,896 |
| 2017-03-07 01:05 | 2017-03-02 | OSUR | ORASURE TECHNOLOGIES INC | Celano Michael | Director | OPT+S | $12.00 | 15,000 | $180,000 | 83,079 |
| 2017-03-07 01:02 | 2017-03-02 | OSUR | ORASURE TECHNOLOGIES INC | TANG STEPHEN S PHD | Director | SELL | $12.02 | 6,100 | $73,346 | 31,968 |
| 2017-03-07 00:22 | 2017-03-02 | TCMD | TACTILE SYSTEMS TECHNOLOGY INC | SHAPIRO STEPHEN I | Director | SELL | $18.82 | 8,000 | $150,558 | 32,460 |
| 2017-03-07 00:22 | 2017-03-02 | TCMD | TACTILE SYSTEMS TECHNOLOGY INC | ROCHE KEVIN H | Director | SELL | $19.07 | 25,000 | $476,683 | 179,474 |
| 2017-03-04 01:50 | 2017-03-03 | BSX | BOSTON SCIENTIFIC CORP | Pierce David A | Officer | SELL | $25.01 | 25,012 | $625,668 | 25,600 |
| 2017-03-04 01:50 | 2017-03-03 | BSX | BOSTON SCIENTIFIC CORP | Pratt Timothy A. | Officer | SELL | $25.01 | 23,540 | $588,846 | 245,846 |
| 2017-03-04 03:20 | 2017-03-01 | CMXC | Stimcell Energetics Inc. | JEFFS RICHARD | 10% owner | BUY | $0.28 | 10,000 | $2,800 | 2,389,416 |
| 2017-03-04 01:03 | 2017-03-01 | PEN | Penumbra Inc | Evans Robert D. | Officer | SELL | $80.03 | 5,000 | $400,150 | 246,296 |
| 2017-03-04 02:22 | 2017-03-02 | PODD | INSULET CORP | Zakrzewski Joseph S | Director | OPT+S | $46.86 | 40,000 | $1,874,496 | 27,849 |
| 2017-03-03 03:34 | 2017-02-28 | BSX | BOSTON SCIENTIFIC CORP | Mirviss Jeffrey B. | Officer | OPT+S | $24.67 | 25,000 | $616,663 | 78,675 |
| 2017-03-03 03:17 | 2017-02-28 | BSX | BOSTON SCIENTIFIC CORP | Dawkins Keith D | Officer | OPT+S | $24.64 | 30,000 | $739,134 | 68,165 |
| 2017-03-03 05:57 | 2017-03-01 | RMD | RESMED INC | Sandercock Brett | Officer | SELL | $72.48 | 1,250 | $90,600 | 65,283 |
| 2017-03-03 00:22 | 2017-02-28 | OSUR | ORASURE TECHNOLOGIES INC | Patrick Charles W | Director | SELL | $11.30 | 5,650 | $63,845 | 9,255 |
| 2017-03-02 00:22 | 2017-02-27 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | Arduini Peter J | Director, Officer | OPT+S | $42.28 | 48,018 | $2,030,230 | 131,555 |
| 2017-03-02 04:32 | 2017-02-27 | LMAT | LEMAITRE VASCULAR INC | LeMaitre George W | Director, Officer, 10% owner | SELL | $22.36 | 10,000 | $223,565 | 82,030 |
| 2017-03-01 23:38 | 2017-02-27 | OSUR | ORASURE TECHNOLOGIES INC | Patrick Charles W | Director | SELL | $11.29 | 29,883 | $337,298 | 60,076 |
| 2017-03-01 19:25 | 2017-02-28 | BAX | BAXTER INTERNATIONAL INC | Third Point LLC | Director | SELL | $50.35 | 5,901,767 | $297,153,968 | 46,001,790 |
| 2017-03-01 00:05 | 2017-02-24 | ANIK | Anika Therapeutics Inc. | Ahn Edward S. | Officer | SELL | $49.47 | 640 | $31,661 | 7,260 |
| 2017-03-01 01:58 | 2017-02-27 | BSX | BOSTON SCIENTIFIC CORP | Pierce David A | Officer | OPT+S | $24.84 | 3,417 | $84,883 | 29,816 |
| 2017-03-01 01:59 | 2017-02-27 | BSX | BOSTON SCIENTIFIC CORP | Pratt Timothy A. | Officer | OPT+S | $24.84 | 4,832 | $120,034 | 240,621 |
| 2017-03-01 00:36 | 2017-02-24 | RMD | RESMED INC | WAREHAM JOHN P | Director | OPT+S | $71.77 | 28,403 | $2,038,455 | 13,000 |
| 2017-03-01 01:17 | 2017-02-24 | CMXC | Stimcell Energetics Inc. | JEFFS RICHARD | 10% owner | BUY | $0.26 | 18,984 | $4,936 | 2,379,416 |
| 2017-02-27 22:12 | 2017-02-24 | ICUI | ICU MEDICAL INC/DE | RIGGS STEVEN | Officer | SELL | $151.99 | 31,250 | $4,749,572 | 1,326 |
| 2017-02-25 00:05 | 2017-02-22 | ANIK | Anika Therapeutics Inc. | Cheung Sylvia | Officer | OPT+S | $49.02 | 4,000 | $196,096 | 37,608 |
| 2017-02-24 17:10 | 2017-02-22 | CRY | Artivion Inc. | Capps Scott B | Officer | OPT+S | $16.40 | 11,083 | $181,776 | 117,394 |
| 2017-02-25 00:05 | 2017-02-22 | ANIK | Anika Therapeutics Inc. | LAND RAYMOND J | Director | SELL | $49.08 | 2,635 | $129,326 | 13,524 |
| 2017-02-24 23:22 | 2017-02-22 | RMD | RESMED INC | ROBERTS CHRISTOPHER G | Director | SELL | $72.10 | 15,000 | $1,081,500 | 298,900 |
| 2017-02-25 03:52 | 2017-02-23 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | Officer | SELL | $78.42 | 3,182 | $249,530 | 12,733 |
| 2017-02-25 03:51 | 2017-02-22 | DXCM | DEXCOM INC | ROPER JESS | Officer | SELL | $78.76 | 2,333 | $183,759 | 10,452 |
| 2017-02-24 00:52 | 2012-03-13 | ATRC | AtriCure, Inc. | Hooven Michael D | Director | SELL | $10.02 | 3,500 | $35,070 | 67,049 |
| 2017-02-24 00:23 | 2017-02-22 | BAX | BAXTER INTERNATIONAL INC | HELLMAN PETER S | Director | OPT+S | $49.81 | 4,280 | $213,187 | 20,140 |
| 2017-02-22 22:48 | 2017-02-15 | PLSE | PULSE BIOSCIENCES, INC. | Zanganeh Maky | Director | BUY | $11.97 | 13,000 | $155,649 | 33,474 |
| 2017-02-23 02:14 | 2017-02-17 | DXCM | DEXCOM INC | SAYER KEVIN R | Director, Officer | OPT+S | $81.62 | 10,000 | $816,177 | 299,391 |
| 2017-02-22 22:48 | 2017-02-09 | PLSE | PULSE BIOSCIENCES, INC. | DUGGAN ROBERT W | 10% owner | BUY | $11.64 | 41,624 | $484,503 | 2,173,359 |
| 2017-02-21 18:57 | 2017-02-16 | ECIA | ENCISION INC | FRIES ROBERT H | Director | BUY | $0.30 | 50,000 | $14,750 | 170,000 |
| 2017-02-21 22:11 | 2017-02-20 | RMD | RESMED INC | ROBERTS CHRISTOPHER G | Director | SELL | $71.91 | 10,000 | $719,100 | 313,900 |
| 2017-02-17 21:50 | 2017-02-15 | SYK | STRYKER CORP | Becker Yin C | Officer | SELL | $125.27 | 4,398 | $550,935 | 12,541 |
| 2017-02-17 19:09 | 2017-02-16 | ECIA | ENCISION INC | Trudel Gregory J. | Director, Officer | BUY | $0.30 | 1,700 | $510 | 11,625 |
| 2017-02-17 01:34 | 2017-02-15 | OSUR | ORASURE TECHNOLOGIES INC | TANG STEPHEN S PHD | Director | OPT+S | $11.04 | 40,000 | $441,756 | 38,068 |
| 2017-02-17 01:33 | 2017-02-16 | OSUR | ORASURE TECHNOLOGIES INC | SPAIR RONALD H | Director, Officer | SELL | $11.12 | 50,000 | $555,780 | 150,063 |
| 2017-02-17 01:31 | 2017-02-15 | OSUR | ORASURE TECHNOLOGIES INC | JERRETT JACK E | Officer | OPT+S | $11.06 | 107,288 | $1,186,477 | 58,842 |
| 2017-02-16 16:57 | 2017-02-15 | BDX | BECTON DICKINSON & CO | SHERMAN JEFFREY S | Officer | OPT+S | $180.02 | 31,464 | $5,664,247 | 22,094 |
| 2017-02-15 22:27 | 2017-02-14 | MMM | 3M CO | Vale Michael G. | Officer | OPT+S | $181.70 | 10,440 | $1,896,953 | 23,295 |
| 2017-02-15 22:20 | 2017-02-14 | MMM | 3M CO | Delgado Joaquin | Officer | OPT+S | $181.62 | 1,142 | $207,406 | 33,563 |
| 2017-02-15 22:06 | 2017-02-14 | MMM | 3M CO | Delgado Joaquin | Officer | OPT+S | $181.55 | 11,609 | $2,107,569 | 34,705 |
| 2017-02-16 01:03 | 2017-02-13 | OSUR | ORASURE TECHNOLOGIES INC | SPAIR RONALD H | Director, Officer | OPT+S | $10.60 | 63,720 | $675,343 | 109,066 |
| 2017-02-15 19:31 | 2017-02-14 | BDX | BECTON DICKINSON & CO | Conroy Alexandre | Officer | SELL | $177.86 | 8,500 | $1,511,810 | 23,676 |
| 2017-02-14 23:22 | 2017-02-13 | MMM | 3M CO | Keel Paul A | Officer | OPT+S | $181.24 | 8,440 | $1,529,705 | 8,776 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Surgical & Medical Instruments & Apparatus
Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.